MedEquities Realty Trust (NYSE: MRT) reported Q1 EPS of $0.16, $0.01 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $15.93 million versus the consensus estimate of $16.57 million.

Highlights – First Quarter and Year to Date

• Reported results attributable to common stockholders for the first quarter of 2018 of net income of $0.16 per diluted share, Funds from Operations ("FFO") of $0.29 per diluted share and Adjusted FFO ("AFFO") of $0.30 per diluted share.
• Invested or committed to invest $29.4 million (up to $73 million if Company purchase options are exercised) in an inpatient psychiatric hospital, an inpatient rehabilitation hospital and a mezzanine loan on an existing skilled nursing/assisted living facility as well as additional fundings on existing investments.
• Increased 2018 per share guidance for net income attributable to common stockholders of $0.64 to $0.66 and reaffirmed 2018 per share guidance for FFO of $1.17 to $1.21 and AFFO of $1.18 to $1.22.
• Declared a regular cash dividend of $0.21 per share for the first quarter of 2018.

Guidance for 2018 For the year ending December 31, 2018, the Company updated its guidance for net income attributable to common stockholders to $0.64 to $0.66 per diluted common share and reaffirmed guidance for FFO of $1.17 to $1.21 per diluted common share and AFFO of $1.18 to $1.22 per diluted common share. While the FFO and AFFO guidance ranges did not change, guidance for net income attributable to common stockholders and certain other reconciling items changed based on the amount and nature of known investment activities to date.

For earnings history and earnings-related data on MedEquities Realty Trust (MRT) click here.